Aerospace Giant TransDigm Expands Empire, Acquires Raptor Scientific For $655M

TransDigm Group is set to acquire Raptor Scientific for $655 million in cash. Raptor Scientific, owned by L Squared Capital Partners, specializes in complex test and measurement solutions for aerospace and defense, generating nearly all revenue from proprietary products.

TransDigm Group Inc (NYSE:TDG) has entered a definitive agreement to acquire Raptor Labs Holdco, LLC, a company owned by L Squared Capital Partners. 

The acquisition, valued at approximately $655 million in cash, includes certain tax benefits.

Raptor Scientific is a global manufacturer of complex test and measurement solutions primarily serving the aerospace and defense end markets. Nearly all of its revenue comes from proprietary products, with significant aftermarket content.

Raptor Scientific, expected to generate $90 million in revenue by the end of 2024, employs around 170 people across various U.S. locations.

Kevin Stein, President and CEO of TransDigm, said, “The Company’s comprehensive proprietary and highly engineered product portfolio of aerospace and defense testing and instrumentation solutions fits well with our value generation strategy.”

The deal is pending regulatory approvals in the U.S. and other customary closing conditions. TransDigm plans to finance the acquisition using existing cash reserves. The company held $4.8 billion in cash and equivalents as of March 30, 2024.

TransDigm Group is a producer and supplier of engineered aerospace components, systems, and subsystems.

Price Action: TDG shares are trading lower by 0.86% at $1,338.74 at the last check Tuesday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo via Shutterstock

Total
0
Shares
Related Posts
Read More

Ontario’s Cannabis Market Heats Up: Shiny Health Buys 10 Stash & Co. Weed Stores, Adding $7.5M To Top Line

Shiny Health & Wellness Corp. has signed an asset purchase agreement with Karan S. Holla for his chain of 10 adult-use cannabis retail stores, Stash & Co. in Ontario. The agreement was signed on December 14, following a previously announced letter of intent in October. The Stash & Co. brand and dispensaries will retain their name and remain unchanged. Shiny Health plans to add the Stash & Co. brand to its existing cannabis consumer program to expand its reach to nearly 100,000 loyal customers. Meris Kott, CEO of Shiny Health & Wellness, expressed excitement about the acquisition and the potential for increased revenue and consumer reach. Shiny Health will continue to conduct final due diligence and finalize lease assignments as part of the transaction, which has a total consideration of CAD 1 million ($750,000), including cash and common shares. The completion of the transaction is subject to approval by the TSXV.

TSXV:SNYB